Click on the links below to view abstracts and posters presented at this congress. All copyright remains that of the copyright holder. This page will be available for a limited period after the congress.
Oral presentation 90 Philis-Tsimikas
Reduced risk of hypoglycaemia and lower HbA1c with degludec compared to glargine U300 in insulin-treated patients with type 2 diabetes
View PDF
Poster presentation 893 Jendle
Real-world cost-effectiveness of insulin degludec in type 1 and type 2 diabetes in a Swedish setting
View PDF
Poster presentation 302 Buse
Outcomes of type 2 diabetes clustering replicated in the DEVOTE trial
View PDF
Poster presentation 894 Ericsson
Cost-effectiveness of insulin degludec vs. insulin glargine U100 in type 1 diabetes in a Swedish setting after one year
View PDF
Poster presentation 793 Feher
Hypoglycaemia, irrespective of the definition used, is reduced when switching to insulin degludec from other basal insulins in routine clinical care: the ReFLeCT study
View PDF